Vycor Medical Inc VYCO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.08
- Day Range
- $0.08–0.08
- 52-Week Range
- $0.04–0.10
- Bid/Ask
- $0.06 / $0.09
- Market Cap
- $2.74 Mil
- Volume/Avg
- 728 / 15,394
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.88
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 8
- Website
- https://www.vycormedical.com
Valuation
|
Metric
|
VYCO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.88 |
Price/Cash Flow | 2,270.27 |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
VYCO
|
|---|---|
Quick Ratio | 0.07 |
Current Ratio | 0.14 |
Interest Coverage | 0.39 |
Quick Ratio
VYCO
Profitability
|
Metric
|
VYCO
|
|---|---|
Return on Assets (Normalized) | −5.70% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
VYCO
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Fnglslw | Scxtfj | $185.5 Bil | |
SYK
| Stryker Corp | Rtctvvtdr | Hbwth | $128.2 Bil | |
MDT
| Medtronic PLC | Hzzxdsq | Qlblr | $106.7 Bil | |
BSX
| Boston Scientific Corp | Ztlybdbdw | Kvwyk | $99.0 Bil | |
DXCM
| DexCom Inc | Zhbslmcmns | Ppcw | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Mmdrjzczm | Grgdf | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Ddkkrtykh | Yqdn | $24.9 Bil | |
ALGN
| Align Technology Inc | Dwzfjjsl | Kgwszjy | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Drcqhxby | Yfdttv | $18.9 Bil | |
PODD
| Insulet Corp | Ggykxhbrvr | Xjrhj | $11.7 Bil |